Boeing has announced the appointment of Tim Buckley, former CEO of The Vanguard Group, to its Board of Directors, effective January 1, 2025. Buckley will bring his extensive experience in investment management to Boeing's Finance and Governance & Public Policy committees.
Boeing has made a significant addition to its Board of Directors by appointing Tim Buckley, the former CEO of The Vanguard Group, as its newest member. This appointment, effective January 1, 2025, was announced by Boeing on November 15, 2024. Buckley will serve on the Finance and Governance & Public Policy committees, bringing his vast experience in managing complex business operations and his familiarity with the investor community to the aerospace giant.
Tim Buckley, 55, has had a distinguished career at The Vanguard Group, one of the largest investment management firms globally, with nearly $10 trillion in assets under management. Under his leadership as CEO, Vanguard's assets grew by 80%, a testament to his strategic focus on product offerings and digital service development aimed at enhancing client success. Before becoming CEO, Buckley held several key positions at Vanguard, including Chief Investment Officer and Chief Information Officer, over his 33-year tenure.
Boeing's Board Chair, Steve Mollenkopf, expressed confidence in Buckley's ability to provide valuable insights and leadership, particularly in navigating complex business landscapes and driving change. Buckley becomes the 12th member of Boeing's board and the tenth new director since 2019, reflecting the company's ongoing efforts to refresh its board with diverse expertise in areas such as aerospace, safety, engineering, and finance.
This strategic appointment is expected to bolster Boeing's governance and policy-making capabilities, aligning with its long-term goals and commitment to innovation and sustainability.
T-Mobile has been targeted in a significant cyber-espionage operation by Chinese hackers, affecting multiple telecom networks globally. Despite the breach, T-Mobile reports no significant impact on its systems or customer data.
The US FDA has approved Syndax Pharmaceuticals' Revuforj, a menin inhibitor, for treating relapsed or refractory acute leukemia with KMT2A translocation in both adults and children.
Super Micro Computer Inc. faces a critical deadline to avoid delisting from the Nasdaq due to delayed financial filings and accounting issues. Despite challenges, the company is working on a compliance plan to maintain its listing.
Apple has removed the US-funded Radio Free Europe/Radio Liberty news app from the Russian App Store following a request from the Russian government, highlighting ongoing tensions over media censorship.
Commerzbank and UniCredit have held a second round of talks focusing on Commerzbank's third-quarter earnings, with no discussion of a potential merger.
Elon Musk has expanded his lawsuit against OpenAI, adding Microsoft as a defendant and alleging antitrust violations. The lawsuit accuses OpenAI and Microsoft of monopolistic practices in the generative AI market.
Mukesh Ambani's Reliance Industries is urging India's telecom regulator to reconsider the allocation method for satellite spectrum, challenging the administrative approach favored by Elon Musk's Starlink and Amazon's Kuiper.